ES2104637T3 - Peptidos con una actividad antagonista para la bombesina/grp. - Google Patents
Peptidos con una actividad antagonista para la bombesina/grp.Info
- Publication number
- ES2104637T3 ES2104637T3 ES91112504T ES91112504T ES2104637T3 ES 2104637 T3 ES2104637 T3 ES 2104637T3 ES 91112504 T ES91112504 T ES 91112504T ES 91112504 T ES91112504 T ES 91112504T ES 2104637 T3 ES2104637 T3 ES 2104637T3
- Authority
- ES
- Spain
- Prior art keywords
- grp
- bombesin
- derivatives
- peptidos
- pump
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000005557 antagonist Substances 0.000 title abstract 2
- 102100036519 Gastrin-releasing peptide Human genes 0.000 abstract 8
- 108010051479 Bombesin Proteins 0.000 abstract 4
- DNDCVAGJPBKION-DOPDSADYSA-N bombesin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC=1NC2=CC=CC=C2C=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1NC(=O)CC1)C(C)C)C1=CN=CN1 DNDCVAGJPBKION-DOPDSADYSA-N 0.000 abstract 4
- 206010060862 Prostate cancer Diseases 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000008485 antagonism Effects 0.000 abstract 1
- 238000010256 biochemical assay Methods 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 238000012875 competitive assay Methods 0.000 abstract 1
- 230000009137 competitive binding Effects 0.000 abstract 1
- 230000002183 duodenal effect Effects 0.000 abstract 1
- 230000027119 gastric acid secretion Effects 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001175 peptic effect Effects 0.000 abstract 1
- 208000000587 small cell lung carcinoma Diseases 0.000 abstract 1
- 230000004614 tumor growth Effects 0.000 abstract 1
- 231100000397 ulcer Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- C07K7/086—Bombesin; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
UN METODO PARA CONTROLAR EL CRECIMIENTO DE TEJIDOS DE TUMORES, ESPECIALMENTE CELULAS PEQUEÑAS DEL PULMON Y CARCINOMAS PROSTATICOS, Y SECRECION ACIDA GASTRICA, CAUSADA Y SINTOMATICA DE, ULCERAS (ESOFAGIALES, GASTRICAS, Y DUODENALES) PEPTICAS. EL TRATAMIENTO COMPRENDE EL ADMINISTRAR A UN PACIENTE EN SU NECESIDAD, UNA CANTIDAD EFICAZ DE UN INHIBIDOR TIPO BOMBESINA/GRP. SE DESCRIBEN ANTAGONISTAS DE BOMBESINA/GRP QUE SON DERIVADOS DE BOMBESINAS/GRP DE OCURRENCIA NATURAL POSEYENDO UNA UNION TIOMETILENA O DE SULFOXIDO DE METILENO CONECTANDO LOS DOS AMINO ACIDOS EN EL EXTREMO TERMINAL CARBOXIDO QUE ES MODIFICADO. SE DESCRIBEN TAMBIEN EL ANTAGONISMO QUE SE CONFIRMA UTILIZANDO UNA UNION COMPETITIVA CONVENCIONAL Y ENSAYOS BIOQUIMICOS ASI COMO EXAMENES FISIOLOGICOS CONVENCIONALES Y EL USO DE ESTOS DERIVADOS EN UNA VARIEDAD DE CONDICIONES EN LAS QUE LA BOMBESINA/GRP ESTA IMPLICADA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55803190A | 1990-07-26 | 1990-07-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2104637T3 true ES2104637T3 (es) | 1997-10-16 |
Family
ID=24227892
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES91112504T Expired - Lifetime ES2104637T3 (es) | 1990-07-26 | 1991-07-25 | Peptidos con una actividad antagonista para la bombesina/grp. |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0468497B1 (es) |
| JP (1) | JP3304993B2 (es) |
| KR (1) | KR100230876B1 (es) |
| AT (1) | ATE153671T1 (es) |
| AU (1) | AU641789B2 (es) |
| DE (1) | DE69126254T2 (es) |
| ES (1) | ES2104637T3 (es) |
| IE (1) | IE912629A1 (es) |
| ZA (1) | ZA915740B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5723578A (en) * | 1987-09-24 | 1998-03-03 | The Administrators Of Tulane Educational Fund | Peptide analogs of bombesin |
| US5877277A (en) | 1987-09-24 | 1999-03-02 | Biomeasure, Inc. | Octapeptide bombesin analogs |
| US5834433A (en) * | 1990-07-26 | 1998-11-10 | Merrell Pharmaceuticals Inc. | Compounds and pharmaceutical uses of peptides of bombesin and GRP |
| EP0626973A1 (en) * | 1992-02-07 | 1994-12-07 | Merrell Pharmaceuticals Inc. | Phenylalanine analogs of bombesin |
| US5436137A (en) * | 1992-07-27 | 1995-07-25 | Oregon Regional Primate Research Center | DNA sequence which encodes a peptide capable of promoting acrosome reaction |
| US6492330B1 (en) | 1996-08-16 | 2002-12-10 | National Institute Of Immunology | Antiangiogenic drugs |
| US6989371B1 (en) | 1996-08-16 | 2006-01-24 | Dabur Research Foundation | Bombesin analogs for treatment of cancer |
| AU2000265053A1 (en) * | 2000-02-24 | 2001-09-03 | Dabur Research Foundation | Bombesin analogs for treatment of cancer |
| NZ564694A (en) | 2003-04-22 | 2009-11-27 | Sod Conseils Rech Applic | Peptide vectors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4331661A (en) * | 1980-10-03 | 1982-05-25 | The Salk Institute For Biological Studies | Bombesin analogs |
| JP2795449B2 (ja) * | 1987-09-24 | 1998-09-10 | ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド | 治療用ペプチド |
| AU618029B2 (en) * | 1987-11-02 | 1991-12-12 | Imperial Chemical Industries Plc | Polypeptide compounds |
| US5019647A (en) * | 1988-05-24 | 1991-05-28 | Merck & Co., Inc. | Gastrin releasing peptide antagonist |
| DE68928667T2 (de) * | 1988-10-14 | 1998-10-01 | Univ Tulane | Peptide als arzneimittel |
| US5028692A (en) * | 1989-04-25 | 1991-07-02 | Merck & Co., Inc. | Gastrin releasing peptide antagonist |
-
1991
- 1991-07-22 ZA ZA915740A patent/ZA915740B/xx unknown
- 1991-07-22 AU AU81236/91A patent/AU641789B2/en not_active Expired
- 1991-07-25 KR KR1019910012753A patent/KR100230876B1/ko not_active Expired - Lifetime
- 1991-07-25 EP EP91112504A patent/EP0468497B1/en not_active Expired - Lifetime
- 1991-07-25 ES ES91112504T patent/ES2104637T3/es not_active Expired - Lifetime
- 1991-07-25 IE IE262991A patent/IE912629A1/en unknown
- 1991-07-25 DE DE69126254T patent/DE69126254T2/de not_active Expired - Lifetime
- 1991-07-25 AT AT91112504T patent/ATE153671T1/de not_active IP Right Cessation
- 1991-07-26 JP JP20881891A patent/JP3304993B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU8123691A (en) | 1992-01-30 |
| DE69126254T2 (de) | 1997-12-04 |
| JP3304993B2 (ja) | 2002-07-22 |
| DE69126254D1 (de) | 1997-07-03 |
| JPH04253997A (ja) | 1992-09-09 |
| KR100230876B1 (ko) | 1999-11-15 |
| EP0468497A3 (en) | 1992-05-06 |
| IE912629A1 (en) | 1992-01-29 |
| AU641789B2 (en) | 1993-09-30 |
| ZA915740B (en) | 1992-05-27 |
| KR920002628A (ko) | 1992-02-28 |
| EP0468497B1 (en) | 1997-05-28 |
| EP0468497A2 (en) | 1992-01-29 |
| ATE153671T1 (de) | 1997-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0403158A3 (en) | Imidazolyl-alkenoic acids | |
| NO882472D0 (no) | Fremgangsmaate for fremstilling av peptidborsyreinhibitorer for trypsinlignende proteaser. | |
| FI905741A0 (fi) | Peptider. | |
| IL83878A0 (en) | Urine factors antagonist to tumor necrosis factor(tnf) | |
| EP0303465A3 (en) | Phenethanolamine derivatives | |
| AU635961B2 (en) | Novel peptidase and isomerase inhibitors | |
| ATE363282T1 (de) | Zusammensetzung zur unterdrückung von magensäure | |
| PH27592A (en) | Imidazolyl-alkenoic acids and its method of use | |
| ES2104637T3 (es) | Peptidos con una actividad antagonista para la bombesina/grp. | |
| DK0585397T3 (da) | Bombesinanaloger | |
| WO2000011000A3 (en) | New compounds | |
| EP0296581A3 (en) | Amino acid 1,2-diketo derivatives as renin inhibitors | |
| WO2000010999A3 (en) | New compounds | |
| NO984950L (no) | Forbindelser med veksthormonfrigj°rende egenskaper | |
| WO1992020651A3 (en) | N-(heteroaryl)-imidazolyl-alkenoic acids | |
| ES2073391T3 (es) | Metodo y composiciones terapeuticas para el tratamiento de trastornos de perdidas de sangre. | |
| EP0102026A3 (en) | Thiazole derivatives | |
| FI872774A7 (fi) | Bentsimidatsolit, niiden valmistus, formulointi ja käyttö mahahappoerityksen inhibiittoreina. | |
| EP0272772A3 (en) | Bronchodilatory peptides | |
| CA2182486A1 (en) | Cyclic neurokinin a antagonists | |
| WO1989010917A3 (en) | Renin inhibitors, process for producing them and use thereof | |
| DE69313850D1 (de) | Veterinaerprodukt zur rehydration | |
| TR200000244T2 (tr) | MCP-1 proteini üretimini azaltmada etkin bir farmasötik bileşim. | |
| EP0266006A3 (en) | Novel hypotensive diuretic peptides | |
| NO924701L (no) | Amid-bundete pyridyl-benzosyrederivater for behandling avleukotrien-relaterte sykdommer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 468497 Country of ref document: ES |